Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

A first for Taiwan, BIO Asia-Taiwan 2019 to be held in Taipei, 24 July, with BIO’s president Jim Greenwood to attend

TAIPEI, TAIWAN – Media_OutReach – 12 June 2019 – At the recently concluded BIO 2019 International Convention, held in Philadelphia, president of BIO (Biotechnology Innovation Organization, the world’s largest biotech industry association) Jim Greenwood met with Johnsee Lee, chairman of the Taiwan Biotechnology Industry Organization (Taiwan BIO) and Wu Tsung-tsong, Minister without Portfolio, the Executive Yuan of Taiwan, to together announce the upcoming BIO Asia-Taiwan 2019 International Conference and Exhibition to be held in Taipei 24-28 July. The theme of this event will be ‘Biotech as the Next Growth Engine for Asia’.
[https://release.media-outreach.com/release.php/Images/Thumb/400×0/21363/TBIO- image.jpg#image-21363] ** Together announcing BIO Asia-Taiwan 2019 during the BIO 2019 Convention in Philadelphia, USA, on 5 June, 2019 are: Jim Greenwood (3rd left) President of BIO; Johnsee Lee (5th left), Chairman of Taiwan BIO; and Wu Tsung-tsong (4th left), Minister without Portfolio, the Executive Yuan of Taiwan.  **
Greenwood noted that the event, co-organized by BIO and Taiwan BIO, is being held in Taiwan for the first time, an important milestone and recognition of Taiwan’s current standing and future potential within the global healthcare industry ecosystem. With Taiwan’s longstanding leadership position in a number of information and communication technology (ICT) industries, and with healthcare moving more and more into the digital realm–combining with advances in AI and Big Data for example–Taiwan is well placed to become an important and essential link in the years to come. Greenwood mentioned that he would be attending BIO Asia-Taiwan in person, and was looking forward to being a part of such an esteemed gathering of international biomedical industry professionals.  
Johnsee Lee, chairman of the steering committee of BIO Asia-Taiwan, noted that the event had attracted significant international interest, with the exhibition hosting pavilions from 18 different countries, including the United States, Canada, the United Kingdom, Switzerland, Italy, South Korea, India, Belgium, Australia, New Zealand, Poland, Thailand, Austria, Hong Kong, Germany, Malaysia, Singapore and the Philippines. The number of overseas exhibitors so far is at least 70, including many multinational pharmaceutical companies. At least 600 companies have confirmed their participation, taking up 1,700 booths on the exhibition floor.
While in Philadelphia for the BIO Convention, Taiwan BIO representatives took the opportunity to call the local industry association Life Sciences Pennsylvania, and also MassBio, the biotech association of Massachusetts. They also met with representatives of the Thailand Center of Excellence for Life Sciences (TCELS), and with KoreaBIO and JBA, the associations of South Korea and Japan respectively, all of who indicated with be sending representatives to Taipei for BIO Asia-Taiwan.
Leading the Taiwan delegation to Philadelphia was Wu Tsung-tsong, Minister without Portfolio, the Executive Yuan of Taiwan. Wu mentioned that in supporting BIO Asia-Taiwan, the government hopes that it will be an opportunity to showcase the country’s strengths and capabilities in biomedical research and development, and highlight its achievements in such sectors as new drug development, diagnostics, biomedical materials and precision medicine. In doing so Wu hopes it will attract more of the global biotech community to Taiwan for business and cooperation engagement.
BIO Asia-Taiwan 2019 Conference Highlights The conference at BIO Asia-Taiwan 2019 will feature international expert speakers on such finance-related topics as cross border financing and investment, M&A, regional cooperation. In ‘breakthrough technologies’, sessions are scheduled on cancer immunotherapies, cell and gene therapy, and regenerative medicine. In so-called ‘game changing technologies’, speakers will deep dive into the exciting disciplines of artificial intelligence, Big Data, IoT, gene sequencing and editing, and liquid biopsies.
Register for BIO Asia-Taiwan 2019 Register now to confirm your ticket to attend the inaugural holding of the BIO Asia-Taiwan 2019 International Conference and Exhibition. This week-long festival of biotech-themed conferences, meetings, presentations and social get- togethers should not be missed! Early Bird discounts end on June 22, so be sure to complete your registration soon!
For more details, visit www.bioasiataiwan.com.